Latent syphilis is the stage of syphilis infection in which the bacterium Treponema pallidum remains in the body but produces no visible symptoms. A person feels fine, looks fine, and has no sores, rashes, or organ problems, yet standard blood tests come back positive for syphilis. The stage can last years or even decades, and it accounts for the majority of syphilis diagnoses in many populations.1Frontiers in Epidemiology. Epidemiological trends of reported syphilis incidence in Xihu district, Hangzhou, China, 2005–2025 Because it is silent, latent syphilis is almost always caught through routine screening rather than a visit prompted by symptoms, which makes understanding what the diagnosis means and what to do about it especially important.
How Syphilis Reaches the Latent Stage
Syphilis moves through a sequence if left untreated. The first stage, primary syphilis, produces a painless sore called a chancre at the site where the bacterium entered the body. That sore heals on its own within a few weeks, often without the person ever noticing it. The second stage, secondary syphilis, brings a body-wide rash, flu-like fatigue, swollen lymph nodes, and sometimes patchy hair loss. These symptoms also clear up without treatment, typically within a few months. Once they do, the infection enters latency.
What happens biologically is a tug-of-war between the bacterium and the immune system. The immune response gradually gains strength, producing antibodies and immune cells that suppress the bacterium’s activity. As that immune pressure builds, the episodes of visible disease (called secondary relapses) become less frequent, and the person eventually transitions into a state where no clinical signs remain.2Microbes and Infection. The immune response to infection with Treponema pallidum, the stealth pathogen The bacteria are not gone; they have retreated into tissues where the immune system cannot fully reach them. This standoff is latent syphilis.
Early Latent Versus Late Latent
Clinicians split latent syphilis into two categories based on timing, and the distinction changes treatment decisions. Early latent syphilis is defined as infection acquired within the past twelve months, even though the person has no symptoms. Late latent syphilis means infection was acquired more than twelve months ago, or the timing simply cannot be determined. In practice, “latent syphilis of unknown duration” gets lumped in with the late latent category because clinicians treat it the same way.
The reason this cutoff matters is transmission risk. During early latency, occasional relapses of secondary symptoms can still occur, meaning the person can potentially pass syphilis to sexual partners. After about a year, those relapses essentially stop, and the risk of sexual transmission drops dramatically. However, a pregnant person with late latent syphilis can still pass the infection to a developing fetus at any point, which is one reason prenatal screening remains standard.
The other reason the distinction matters is treatment dose. Early latent syphilis is treated with a single injection of penicillin, while late latent syphilis requires three injections given a week apart. We will come back to that protocol in detail shortly.
Why There Are No Visible Symptoms
Treponema pallidum is sometimes called the “stealth pathogen” for good reason. It has an unusually sparse outer membrane with very few surface proteins for the immune system to latch onto, which helps it evade detection even while provoking a measurable antibody response. During latency, the immune system is strong enough to suppress active disease but not strong enough to clear the infection entirely. The result is a biological stalemate: you feel healthy, your body is producing anti-syphilis antibodies, and the bacteria persist in small numbers in places like the central nervous system, the liver, and the lymph nodes.
This is why latent syphilis cannot be diagnosed by physical examination. There is literally nothing to see. The only way to detect it is through blood testing, which picks up the antibodies your body is making against the bacterium.
How Latent Syphilis Is Diagnosed
Syphilis blood tests come in two families. Non-treponemal tests measure your body’s inflammatory response to tissue damage caused by the infection. The most common ones are the RPR and VDRL. Treponemal tests look for antibodies directed specifically at the syphilis bacterium itself. Common treponemal tests include the FTA-ABS and various enzyme or chemiluminescence-based assays used in automated lab platforms.
Traditionally, screening started with a non-treponemal test and then confirmed positive results with a treponemal test. Many labs have now flipped that order, starting with an automated treponemal test and then following up with the RPR. This “reverse algorithm” picks up more cases, particularly latent ones. One study at a national referral lab found that the reverse approach identified a significantly higher proportion of syphilis cases compared to the traditional method and had a much lower rate of missed diagnoses.3PubMed Central. Traditional versus reverse algorithm for diagnosis of syphilis – An Indian perspective from a national referral laboratory for sexually transmitted infections After Alberta, Canada, adopted the reverse sequence, clinicians there saw a notable increase in late latent syphilis diagnoses, essentially finding infections that would have been missed under the old approach.4PubMed. Impact of reverse sequence syphilis screening on new diagnoses of late latent syphilis in Edmonton, Canada
That said, the reverse algorithm is better at catching latent infections, while the traditional method still has value in monitoring active disease and treatment response.5Journal of Pharmaceutical Research and Integrated Medical Sciences. Syphilis Infection, Clinical Synergies, Modern Diagnostic and Treatment Strategies, Epidemiological Impact: Review of Traditional and Reverse Screening Algorithms Many clinics now use elements of both, running the treponemal test first for screening and tracking the RPR titer over time to see whether treatment is working.
When Blood Tests Get It Wrong
A frustrating reality of syphilis testing is that false positives occur, and they are not always easy to sort out. Non-treponemal tests can be triggered by a wide range of conditions that have nothing to do with syphilis. One study examining confirmed false-positive RPR results found that cancers were the most common underlying condition, followed by digestive diseases and other infections. Infectious mononucleosis caused by the Epstein-Barr virus stood out as an unusual case, producing much higher false RPR titers than other causes of false positives.6PubMed. Epstein-Barr virus-associated infectious mononucleosis exhibits substantially higher non-treponemal test titers in biological false-positive reactions
Even treponemal tests, which are supposed to be more specific, are not immune to false results. Research in patients with diabetes found that about five percent had unexplained false-positive treponemal test results, while others showed cross-reactivity with the bacterium responsible for Lyme disease.7PubMed. False-positive treponemal serology in patients with diabetes mellitus For someone who screens positive during a routine blood draw but has no history of syphilis exposure, these false-positive scenarios can create real anxiety and confusion. A clinician typically sorts it out by looking at both test types together along with the patient’s medical history, but the process can take weeks.
Treatment for Early and Late Latent Syphilis
Penicillin has been the standard treatment for syphilis since the 1940s, and nothing has displaced it. For early latent syphilis, treatment is a single intramuscular injection of benzathine penicillin G at a dose of 2.4 million units. For late latent syphilis or latent syphilis of unknown duration, the standard regimen is three of those injections, one per week for three consecutive weeks.8The Indonesian Journal of General Medicine. Comparing Single-Dose Versus Multi-Dose Benzathine Penicillin G for the Treatment of Late Latent Syphilis: A Systematic Review of Randomized Controlled Trials and Primary Studies
The three-dose regimen for late latent syphilis sounds straightforward, but adherence is a real problem. Life gets in the way. Patients miss appointments. Clinics can be hard to get back to. Emerging research has begun to question whether all three doses are truly necessary, since the evidence supporting three doses over one for late latent disease is surprisingly thin. Still, current guidelines maintain the three-dose standard, and most clinicians follow that recommendation.
If you are allergic to penicillin, the picture gets trickier. A large systematic review and network analysis found that ceftriaxone, given as a course of daily injections, showed a slightly higher treatment response rate than penicillin at six months and appears to be the best alternative.9PubMed Central. Efficacy and Safety of Treatments for Different Stages of Syphilis: a Systematic Review and Network Meta-Analysis of Randomized Controlled Trials and Observational Studies Doxycycline is another option mentioned in guidelines, and one study of people living with HIV found that doxycycline performed as a viable alternative to penicillin for latent syphilis treatment.10PubMed Central. Investigating latent syphilis in HIV treatment-experienced Ethiopians and response to therapy However, data supporting other alternatives like erythromycin or tetracycline for syphilis are limited, and those drugs are generally considered less reliable.
The Jarisch-Herxheimer Reaction
Some people feel significantly worse within hours of their first penicillin injection. This is not an allergic reaction and it does not mean the treatment failed. It is called the Jarisch-Herxheimer reaction, and it happens because the rapid killing of syphilis bacteria triggers a burst of inflammation. In a clinical trial analyzing the reaction in early syphilis patients, roughly one in four experienced it, most commonly as muscle aches, chills, weakness, and feverishness. Symptoms typically started within five hours and resolved within about thirteen hours.11PubMed Central. Jarisch-Herxheimer Reaction After Benzathine Penicillin G Treatment in Adults With Early Syphilis: Secondary Analysis of a Randomized Clinical Trial
Interestingly, the reaction is more common in early syphilis (when bacterial load is higher) than in latent syphilis, and it may actually be a sign of a strong treatment response. That same study found that people who experienced the reaction were more likely to show a good serological response at six months compared to those who did not. The reaction is self-limiting, meaning it resolves on its own. Over-the-counter fever reducers and rest are usually all that is needed. The critical thing for both patients and clinicians is to distinguish it from a true penicillin allergy, which would involve hives, breathing difficulty, or anaphylaxis rather than flu-like symptoms.12INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH. WHEN THE TREATMENT STRIKES BACK: A CASE SERIES ON JARISCH HERXHEIMER REACTION IN SYPHILIS
The Serofast Problem After Treatment
After treatment, clinicians track your RPR titer over time. A successful cure is indicated by a fourfold drop in titer, such as going from 1:32 down to 1:8. But a sizable number of treated patients never achieve that drop. Their titers stabilize at a low but persistent level, a condition called the serofast state. One review found that roughly two-thirds of serofast patients did not achieve a further serological cure even after twelve months of additional treatment, and about half still had detectable non-treponemal antibodies after two years of continued follow-up.13Clinica Chimica Acta. Review Serofast status in syphilis: Pathogenesis to therapeutics
This creates a dilemma. Does the persistent positive test mean the bacteria are still alive and the patient needs more treatment? Or is it just the immune system continuing to produce antibodies against an infection that is already gone? The prevailing expert view leans toward the latter explanation. The serofast state appears to reflect a lingering immune response rather than active infection, which means retreatment often does not help. A three-dose retreatment regimen may provide some benefit in a subset of patients, but current CDC guidance acknowledges there is not enough evidence to draw firm conclusions.14Advances in Dermatology and Allergology. Serofast state after syphilis treatment: implications and recommendations for clinical practice. Narrative review Most experts agree that if there are no signs of neurological, cardiovascular, or other organ involvement, patients in the serofast state do not need aggressive retreatment.
Latent Syphilis and HIV
Syphilis and HIV frequently travel together. People living with HIV are more likely to be diagnosed with syphilis, and syphilis can increase susceptibility to HIV by disrupting mucosal barriers. A natural question for anyone with both infections is whether HIV changes how well syphilis treatment works.
The reassuring finding from multiple studies is that HIV status does not appear to meaningfully alter treatment outcomes for latent syphilis. One study found that treatment failure in HIV-positive patients was driven by a slower decline in antibody titers rather than an actual lack of response to penicillin.15PubMed. The outcome of treatment of early latent syphilis and syphilis with undetermined duration in HIV-infected and HIV-uninfected patients In other words, the infection clears, but the blood tests take longer to reflect it. Antiretroviral therapy for HIV also appears to improve the serological response to syphilis treatment, adding another reason to maintain consistent HIV treatment.10PubMed Central. Investigating latent syphilis in HIV treatment-experienced Ethiopians and response to therapy
One area where HIV does complicate matters is the question of whether to perform a lumbar puncture (spinal tap) to check for neurosyphilis. Guidelines have historically recommended lumbar puncture for people with HIV and latent syphilis, but evidence suggests that in the absence of neurological symptoms, the procedure contributes little. A study of hospitalized patients with latent syphilis found that while cerebrospinal fluid abnormalities were common in HIV-positive patients, these abnormalities were not caused by neurosyphilis and did not change treatment decisions.16PubMed. Lumbar puncture for evaluation of latent syphilis in hospitalized patients. High prevalence of cerebrospinal fluid abnormalities unrelated to syphilis.
Complications That Can Surface During Latency
Although latent syphilis is defined by the absence of symptoms, the infection is not necessarily dormant in every organ. The eyes are a particularly vulnerable site. One case report described a patient with no known history of syphilis who developed unexplained inflammation after routine cataract surgery. The inflammation did not respond to standard post-surgical treatment but resolved completely once the underlying latent syphilis was diagnosed and treated with intravenous penicillin.17PubMed. Postoperative inflammation as the presenting sign of latent syphilis Ocular syphilis is now recognized as something that can occur at any stage of the disease, and unexplained eye inflammation is considered a reason to test for syphilis even in the absence of other risk factors.
If latent syphilis is left untreated for years, a fraction of patients will eventually develop tertiary syphilis, which can damage the heart, blood vessels, brain, and other organs. Tertiary disease is now uncommon in countries with widespread screening, but it still occurs. Cardiovascular syphilis, which typically appears ten to thirty years after the original infection, can cause aortic aneurysms. Neurosyphilis can produce dementia, difficulty walking, and personality changes. These are the outcomes that treatment during the latent stage is meant to prevent.
The Scale of the Problem
Syphilis is not a relic of the past. Global estimates suggest that over 45 million people were living with syphilis as of 2015, with close to 6 million new infections each year and more than 107,000 deaths attributed to the disease.18PubMed Central. The Epidemiology of Syphilis Worldwide in the Last Decade Rates have been climbing since 2010 in many countries, and projections suggest that trend will continue or plateau through 2035, particularly among younger adults.
Within this surge, latent syphilis consistently accounts for the largest share of reported cases. Epidemiological data from one Chinese district spanning twenty years showed that latent syphilis dominated all stages throughout the entire study period, while primary and secondary syphilis cases actually trended downward over time.1Frontiers in Epidemiology. Epidemiological trends of reported syphilis incidence in Xihu district, Hangzhou, China, 2005–2025 This pattern likely reflects two overlapping realities: better screening catches more latent infections, and people who do not get treated during the symptomatic stages accumulate in the latent pool over time.
Why Partner Notification Struggles
One of the most difficult aspects of latent syphilis from a public health standpoint is contact tracing. When someone is diagnosed with primary or secondary syphilis, they can usually recall recent sexual partners and provide enough information for health departments to reach out. Latent syphilis, especially late latent, makes this nearly impossible. The infection may have been acquired years ago, and the person may have no idea who gave it to them or when.
The numbers paint a stark picture. A review of partner services across Georgia from 2013 to 2024 found that of all eligible syphilis patients, only about sixty percent completed an interview, roughly a quarter named a partner with enough identifying details for outreach, and just nine percent had a partner who actually received treatment. Of all potentially exposed partners, only about ten percent could even be located, and that proportion worsened over time, with unlocatable partners rising from eighty-six percent to ninety-five percent over the study decade.19PubMed Central. Assessing Syphilis Partner Services in Georgia (2013-2024): Effectiveness in Partner Notification and Impact on Reinfection Even more concerning, having at least one unlocatable partner was associated with a roughly forty percent higher likelihood of syphilis reinfection within two years.
A separate analysis across seven U.S. jurisdictions found that after adjusting for timing, only about eleven percent of named partners were treated within ninety days of the patient’s interview, with wide variation between programs.20PubMed Central. Effectiveness of syphilis partner notification after adjusting for treatment dates, 7 jurisdictions These are sobering numbers. They explain, at least in part, why syphilis continues to spread despite being readily curable: the infections we can treat are only a fraction of the infections circulating in a population, and the latent stage is where most of the undetected reservoir sits.